Jobe P C, Mishra P K, Ludvig N, Dailey J W
Department of Basic Sciences, University of Illinois College of Medicine, Peoria 61656.
Crit Rev Neurobiol. 1991;6(3):183-220.
Studies of the genetic models of the epilepsies emphasize that some seizure disorders result from an aberrant "wiring diagram" coupled with abnormal activity of individual neurons. These defects cause the unique seizer-triggering mechanisms operative within the epileptic nervous system but which are inactive or do not exist in normal subjects. Moreover, causes of epilepsy reside not only within the brain area, wherein initial appearance of epileptic EEG discharge occurs, but also outside that region. Etiologically significant neurochemical dysfunctions may be common features of the epileptic condition in genetic models across species. Accordingly, genetically determined convulsive epileptogenesis in rats, baboons, and humans may result partially from noradrenergic and GABAergic deficits. In contrast, genetically derived absence seizures in the rat and perhaps also humans may occur in response to GABAergic excess. The unique features of the genetically epileptic animals emphasize their usefulness in developing novel drugs that selectively ameliorate seizure predisposition.
对癫痫遗传模型的研究强调,一些癫痫发作障碍是由异常的“布线图”以及单个神经元的异常活动导致的。这些缺陷导致了癫痫神经系统内独特的癫痫发作触发机制,而这些机制在正常个体中不活跃或不存在。此外,癫痫的病因不仅存在于首次出现癫痫性脑电图放电的脑区,还存在于该区域之外。具有病因学意义的神经化学功能障碍可能是跨物种遗传模型中癫痫状况的共同特征。因此,大鼠、狒狒和人类中由基因决定的惊厥性癫痫发生可能部分源于去甲肾上腺素能和γ-氨基丁酸能缺陷。相比之下,大鼠以及可能人类中由基因导致的失神发作可能是对γ-氨基丁酸能过量的反应。遗传性癫痫动物的独特特征凸显了它们在开发选择性改善癫痫易感性的新型药物方面的有用性。